OpenClinica: Open Source Platform for Clinical Research
OpenClinica:临床研究开源平台
基本信息
- 批准号:8005812
- 负责人:
- 金额:$ 28.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-10 至 2011-06-09
- 项目状态:已结题
- 来源:
- 关键词:AddressBiological ProductsBusinessesCase Report FormClinicalClinical ResearchCodeCommunitiesComputer SystemsComputer softwareConnecticutDataData SourcesDefectDevelopmentDocumentationElectronicsEnvironmentGood Clinical PracticeGovernment AgenciesGrowthHeadHealthHealthcareIncentivesIndustryInstitute of Medicine (U.S.)InternationalLicensingMaintenanceMetadataModelingMonitorPaperPatient Outcomes AssessmentsPatientsPeer ReviewPhaseProcessPublished CommentResearchResearch ContractsResearch InfrastructureRewardsScienceSemanticsServicesSmall Business Innovation Research GrantSolutionsSourceSystemTechnologyTestingTranslational ResearchUnited States National Institutes of HealthUniversitiesValidationVendorWorkbasecluster computingcohesiondata exchangedesigndiarieselectronic dataempoweredfederated computingflexibilityimprovedinnovationinteroperabilitymeetingsmodel developmentopen sourcepublic health researchresearch and developmentresearch studysoftware developmentsoftware systemssyntaxtheoriestool
项目摘要
DESCRIPTION (provided by applicant): We believe a key barrier to transforming clinical research is the lack of open, integrated, transparent technology solutions that address bottlenecks in information integration and business process management. Our viewpoint is supported by a recent Forrester Research study that identifies proprietary software as "one of the biggest barriers" to interoperability in the health IT environment, and suggests wider use of open source software to address integration challenges. I This project will build on Akaka's OpenClinica platform, the leading open source clinical research solution, to develop a broad-based open source software infrastructure that enables interoperability in heterogeneous clinical and translational research, and to develop targeted commercially-supported open source solutions from this infrastructure. It will: Integrate research data across distributed heterogeneous data sources, even data from legacy sources with poor interfaces and data documentation. Automate exchange of information with other systems in the healthcare and clinical research enterprises via semantically harmonized domain models and standardized messaging interfaces. Facilitate transition of paper-based processes to electronic systems for electronic data capture of case report forms (CRFs) and patient diaries (ePRO, or electronic Patient Reported Outcomes). Improve research management and monitoring in a Good Clinical Practice-compliant environment. The resulting solution will advance the capabilities of the clinical and translational research enterprise and empower collaborative research at Academic Health Centers (AHCs), government agencies, Contract Research Organizations (CROs), and the biopharmaceutical industry. It will increase the throughput and efficiency of clinical research, operate reliably in heterogeneous environments, and enable new types of research by bringing together disparate research tools and data.
描述(由申请人提供):我们认为,转变临床研究的一个关键障碍是缺乏开放、集成、透明的技术解决方案,以解决信息集成和业务流程管理方面的瓶颈。Forrester Research最近的一项研究支持了我们的观点,该研究将专有软件确定为医疗IT环境中互操作性的“最大障碍之一”,并建议更广泛地使用开源软件来解决集成挑战。该项目将建立在Akaka的OpenClinica平台(领先的开源临床研究解决方案)上,开发一个广泛的开源软件基础设施,使异构临床和转化研究能够互操作性,并从该基础设施开发有针对性的商业支持的开源解决方案。它将:集成跨分布式异构数据源的研究数据,甚至是来自接口和数据文档较差的遗留数据源的数据。通过语义协调的领域模型和标准化消息传递接口,自动与医疗保健和临床研究企业中的其他系统交换信息。促进纸质流程向电子系统过渡,以获取病例报告表格(CRFs)和患者日记(ePRO或电子患者报告结果)的电子数据。在符合良好临床规范的环境中改进研究管理和监测。由此产生的解决方案将提高临床和转化研究企业的能力,并增强学术健康中心(AHCs)、政府机构、合同研究组织(cro)和生物制药行业的合作研究能力。它将提高临床研究的吞吐量和效率,在异构环境中可靠地运行,并通过汇集不同的研究工具和数据来实现新型研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAL T COLLINS其他文献
CAL T COLLINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAL T COLLINS', 18)}}的其他基金
PhenoNet: Distributed Repositories for Phenotypic Data
PhenoNet:表型数据的分布式存储库
- 批准号:
6936635 - 财政年份:2004
- 资助金额:
$ 28.98万 - 项目类别:
PhenoNet: Distributed Repositories for Phenotypic Data
PhenoNet:表型数据的分布式存储库
- 批准号:
6790736 - 财政年份:2004
- 资助金额:
$ 28.98万 - 项目类别:
OpenClinica: Open Source Platform for Clinical Research
OpenClinica:临床研究开源平台
- 批准号:
7329355 - 财政年份:2004
- 资助金额:
$ 28.98万 - 项目类别:
OpenClinica: Open Source Platform for Clinical Research
OpenClinica:临床研究开源平台
- 批准号:
7478849 - 财政年份:2004
- 资助金额:
$ 28.98万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 28.98万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 28.98万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 28.98万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 28.98万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 28.98万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 28.98万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 28.98万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 28.98万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 28.98万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 28.98万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)